Phase I STEBVax in Healthy Adults

Clinical trial NCT00974935 · COMPLETED

Trial details

NCT number: NCT00974935
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Toxic Shock Syndrome Staphylococcal

Start date: 2011-02-01
Primary completion: 2015-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.